AQILION AB
556623-2095ActiveDeveloping innovative treatments for chronic inflammatory diseases via early-stage partnering.
Overview
- 5–9
- Employees
- 2.5–5M SEK
- Revenue
- 2002
- Founded
Description
Aqilion is a Swedish biotech company dedicated to developing innovative new treatments for diseases stemming from chronic inflammation and dysfunctional immunological reactions, such as autoimmune disorders. Their core mission involves identifying promising scientific ideas based on solid biological...
Tags
Keywords
Company Information
- Industry
- Konsultverksamhet avseende företags organisation
- Legal Form
- Aktiebolag
- VAT Number
- SE556623209501
Decision Makers
No decision makers found yet
Similar Companies
20 similar companies in FunnelfeedrTribune Therapeutics AB
1–4 employeesDeveloping novel medicines to halt fibrotic disease progression across organs.
Oxion Biologics AB
1–4 employeesRevolutionizing treatment for immune-mediated diseases with novel therapy.
Transient Pharma AB
0 employeesDeveloping peptide drugs targeting severe inflammatory diseases using natural templates.
GLYCOREX TRANSPLANTATION AB (PUBL)
10–19 employeesDevelops technology to remove blood antibodies for transplants and disease.
Active Biotech AB (publ)
1–4 employeesDeveloping novel treatments for cancer and inflammatory eye diseases.
Browse More
AQILION AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo